4CHL image
Entry Detail
PDB ID:
4CHL
Keywords:
Title:
Human Ethylmalonic Encephalopathy Protein 1 (hETHE1)
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2013-12-03
Release Date:
2014-12-17
Method Details:
Experimental Method:
Resolution:
2.61 Å
R-Value Free:
0.22
R-Value Work:
0.17
R-Value Observed:
0.18
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:PERSULFIDE DIOXYGENASE ETHE1, MITOCHONDRIAL
Chain IDs:A, B
Chain Length:238
Number of Molecules:2
Biological Source:HOMO SAPIENS
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CSD A CYS 3-SULFINOALANINE
Ligand Molecules
Primary Citation
Crystal structure of human persulfide dioxygenase: structural basis of ethylmalonic encephalopathy.
Hum. Mol. Genet. 24 2458 2469 (2015)
PMID: 25596185 DOI: 10.1093/hmg/ddv007

Abstact

The ethylmalonic encephalopathy protein 1 (ETHE1) catalyses the oxygen-dependent oxidation of glutathione persulfide (GSSH) to give persulfite and glutathione. Mutations to the hETHE1 gene compromise sulfide metabolism leading to the genetic disease ethylmalonic encephalopathy. hETHE1 is a mono-iron binding member of the metallo-β-lactamase (MBL) fold superfamily. We report crystallographic analysis of hETHE1 in complex with iron to 2.6 Å resolution. hETHE1 contains an αββα MBL-fold, which supports metal-binding by the side chains of an aspartate and two histidine residues; three water molecules complete octahedral coordination of the iron. The iron binding hETHE1 enzyme is related to the 'classical' di-zinc binding MBL hydrolases involved in antibiotic resistance, but has distinctive features. The histidine and aspartate residues involved in iron-binding in ETHE1, occupy similar positions to those observed across both the zinc 1 and zinc 2 binding sites in classical MBLs. The active site of hETHE1 is very similar to an ETHE1-like enzyme from Arabidopsis thaliana (60% sequence identity). A channel leading to the active site is sufficiently large to accommodate a GSSH substrate. Some of the observed hETHE1 clinical mutations cluster in the active site region. The structure will serve as a basis for detailed functional and mechanistic studies on ETHE1 and will be useful in the development of selective MBL inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures